Cell Source, Inc.
CLCS
$0.25
-$0.02-7.41%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.10% | -30.78% | -27.40% | -16.56% | -9.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.46% | 31.83% | -19.60% | -19.23% | -2.03% |
| Operating Income | 16.46% | -31.83% | 19.60% | 19.23% | 2.03% |
| Income Before Tax | -5.90% | -19.91% | 24.60% | 21.49% | -6.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.90% | -19.91% | 24.60% | 21.49% | -6.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.90% | -19.91% | 24.60% | 21.49% | -6.85% |
| EBIT | 16.46% | -31.83% | 19.60% | 19.23% | 2.03% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 3.25% | -7.73% | 26.26% | 22.99% | 2.05% |
| Normalized Basic EPS | 3.65% | -5.09% | 30.88% | 37.97% | 1.35% |
| EPS Diluted | 3.25% | -7.73% | 26.26% | 22.99% | 2.05% |
| Normalized Diluted EPS | 3.65% | -5.09% | 30.88% | 37.97% | 1.35% |
| Average Basic Shares Outstanding | 11.09% | 10.23% | 9.30% | 9.68% | 8.37% |
| Average Diluted Shares Outstanding | 11.09% | 10.23% | 9.30% | 9.68% | 8.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |